$IMCR Balance Sheet | Understand Stock

$IMCR

$31.96 +$0.68 (2.17%) Close

$IMCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020
Property, plant and equipment
Intangible assets
Right of use assets
Investment in sub-lease
Other non-current assets
Deferred tax asset
Total non-current assets
Inventory
Trade and other receivables
Tax receivable
Embedded derivative assets
Cash and cash equivalents
Total current assets
Total assets
Share capital
Share premium
Foreign currency translation reserve
Other reserves
Share-based payment reserve
Accumulated deficit
Total equity
Non-current accruals
Interest-bearing loans and borrowings
Deferred liabilities
Deferred revenue
Lease liabilities
Provisions
Total non-current liabilities
Trade and other payables
Tax payable
Derivative liabilities
Total current liabilities
Total liabilities
Assets
Current assets
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Prepaid expenses and other current assets
Tax receivable
Inventory, net
Total current assets
Property and equipment, net
Operating lease right of use assets, net
Deferred tax assets, net
Other non-current assets
Total assets
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue, current
Operating lease liabilities, current
Interest-bearing loans and borrowings, current
Total current liabilities
Accrued expenses, non-current
Deferred revenue, non-current
Operating lease liabilities, non-current
Interest-bearing loans and borrowings
Total liabilities
Shareholders’ equity
Ordinary shares (voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £149,303 and £149,633 shares as of June 30, 2026 and December 31, 2025, respectively, and 51,480,159 and 50,689,271 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity
Common stock, shares outstanding (in shares)

Comments